DEA Notice of Application for Controlled Substance Import Registration

Regs.gov: Drug Enforcement Administration

Published March 18th, 2026

Detected March 20th, 2026

Summary

The Drug Enforcement Administration (DEA) has published a notice regarding an application from Siegfried Grafton, Inc. to be registered as an importer of specific controlled substances, including Gamma Hydroxybutyric Acid and Marihuana. Registered bulk manufacturers and other applicants may submit comments or requests for a hearing by April 20, 2026.

View original document View source feed page

What changed

The Drug Enforcement Administration (DEA) has issued a notice concerning an application from Siegfried Grafton, Inc. for registration as an importer of controlled substances. The application includes basic classes such as Gamma Hydroxybutyric Acid, Marihuana Extract, Marihuana, 3,4-Methylenedioxymethamphetamine, and Dimethyltryptamine. The company intends to import these substances for analytical testing or distribution, with no other activities authorized under this registration.

Registered bulk manufacturers of the affected controlled substances and other applicants have until April 20, 2026, to submit electronic comments or objections to the proposed registration. They may also file a written request for a hearing by the same date. Comments must be submitted electronically via the Federal eRulemaking Portal, while hearing requests must be sent to specific DEA addresses.

What to do next

Submit electronic comments or objections by April 20, 2026
File written request for hearing by April 20, 2026

Source document (simplified)

Content

ACTION:

Notice of application.

SUMMARY:

Siegfried Grafton, Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to

     Supplementary Information
     listed below for further drug information.

DATES:

Registered bulk manufacturers of the affected basic class(es), and applicants, therefore, may submit electronic comments on
or objections to the issuance of the proposed registration on or before April 20, 2026. Such persons may also file a written
request for a hearing on the application on or before April 20, 2026.

ADDRESSES:

The Drug Enforcement Administration requires that all comments be submitted electronically through the Federal eRulemaking
Portal, which provides the ability to type short comments directly into the comment field on the web page or attach a file
for lengthier comments. Please go to https://www.regulations.gov and follow the online instructions at that site for submitting comments. Upon submission of your comment, you will receive
a Comment Tracking Number. Please be aware that submitted comments are not instantaneously available for public view on https://www.regulations.gov. If you have received a Comment Tracking Number, your comment has been successfully submitted and there is no need to resubmit
the same comment. All requests for a hearing must be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/OALJ,
8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing should also be sent to: Drug Enforcement Administration,
Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION:

In accordance with 21 CFR 1301.34(a), this is notice that on February 25, 2026, Siegfried Grafton, Inc., 870 Badger Circle,
Grafton, Wisconsin 53024-9436, applied to be registered as an importer of the following basic class(es) of controlled substance(s):

| Controlled substance | Drug
code | Schedule |
| --- | --- | --- |
| Gamma Hydroxybutyric Acid | 2010 | I |
| Marihuana Extract | 7350 | I |
| Marihuana | 7360 | I |
| 3,4-Methylenedio- xymethamphetamine | 7405 | I |
| Dimethyltryptamine | 7435 | I |
The company plans to import the listed controlled substances for analytical testing or distribution. No other activities for
these drug codes are authorized for this registration.

Approval of permit applications will occur only when the registrant's business activity is consistent with what is authorized
under 21 U.S.C. 952(a)(2). Authorization will not extend to the import of Food and Drug Administration-approved or non-approved
finished dosage forms for commercial sale.

Thomas Prevoznik, Deputy Assistant Administrator [FR Doc. 2026-05356 Filed 3-18-26; 8:45 am] BILLING CODE P